SCHEMBL30294334

SCHEMBL30294334

Cc1ncccc1-c1cc(C(F)(F)F)ccc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 1/20 0.47
▸ SORT1 Q99523 11/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ DHODH Q02127 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ GMNN O75496 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ TTR P02766 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ UGT1A1 P22309 1/20 0.47
▸ PTGS1 P23219 1/20 0.47
▸ PTGS2 P35354 1/20 0.47
▸ PMP22 Q01453 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ TEAD4 Q15561 1/20 0.47
▸ HIF1A Q16665 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22853133 0.78 TAS2R14 (0.62) SORT1ALDH1A1DHODHMEN1GMNN
SCHEMBL4661838 0.78 SCN8A (0.62) SORT1ALDH1A1DHODHMEN1GMNN
SCHEMBL14697587 0.77 TRPV1 (0.49) GPBAR1SORT1ALDH1A1DHODHMEN1
SCHEMBL14398076 0.76 KDM4E (0.51) SORT1ALDH1A1MEN1CYP3A4CYP2C9
SCHEMBL3872238 0.75 EIF4E (0.47) ALDH1A1DHODHLMNACYP3A4PTGS1
SCHEMBL31449913 0.74 ALDH1A1 (0.51) SORT1ALDH1A1DHODHMEN1KMT2A
SCHEMBL14398077 0.73 KDM4E (0.51) SORT1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL421844 0.73 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDHSD17B10USP2
SCHEMBL23354125 0.73 RXRA (0.54) SORT1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL18373464 0.73 SORT1 (0.51) SORT1ALDH1A1DHODHMEN1GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230103791-A1 2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-04-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230103791-A1 2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS SCN8A, SCN1A, SCN1B GPBAR1 1214/4885SORT1 3573/4885ALDH1A1 3102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback